Phenotypic Spectrum of Dystrophinopathy Due to Duchenne Muscular Dystrophy Exon 2 Duplications.
Alberto Andrea ZambonMegan A WaldropRoxane AllesRobert B WeissSara ConroyMelissa Moore-ClingenpeelPrevitali Stefano CarloKevin M Flanigannull nullPublished in: Neurology (2021)
Some patients with Dup2 display a milder disease course than controls without Dup2 DMD, and prolonged ambulation with corticosteroids suggests the potential of IRES activation as a molecular mechanism. As Dup2-targeted therapies reach clinical applications, this information is critical to aid in the interpretation of the efficacy of new treatments.